N-[3-[3-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]imidazo[1,2-a]pyridin-5-yl]oxypentyl]acetamide
C24H25F2N5O2 — CID 142403721
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[3-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]imidazo[1,2-a]pyridin-5-yl]oxypentyl]acetamide
N-[3-[3-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]imidazo[1,2-a]pyridin-5-yl]oxypentyl]acetamide (PubChem CID 142403721) has the molecular formula C24H25F2N5O2 and a molecular weight of 453.49 g/mol. Its IUPAC name is N-[3-[3-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]imidazo[1,2-a]pyridin-5-yl]oxypentyl]acetamide.
Molecular Properties
| Compound Name | N-[3-[3-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]imidazo[1,2-a]pyridin-5-yl]oxypentyl]acetamide |
|---|---|
| PubChem CID | 142403721 |
| Molecular Formula | C24H25F2N5O2 |
| Molecular Weight | 453.49 g/mol |
| Exact Mass | 453.20 |
| IUPAC Name | N-[3-[3-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]imidazo[1,2-a]pyridin-5-yl]oxypentyl]acetamide |
| SMILES | CCC(CCNC(C)=O)Oc1cccc2ncc(-c3ccc(-c4cnn(C(F)F)c4)cc3)n12 |
| InChI | InChI=1S/C24H25F2N5O2/c1-3-20(11-12-27-16(2)32)33-23-6-4-5-22-28-14-21(31(22)23)18-9-7-17(8-10-18)19-13-29-30(15-19)24(25)26/h4-10,13-15,20,24H,3,11-12H2,1-2H3,(H,27,32) |
| InChIKey | SIWMZTCMIHHPSJ-UHFFFAOYSA-N |
| XLogP | 4.94 |
| TPSA | 73.45 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 453.49 |
| LogP ≤ 5 | 4.94 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142403721 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.